Correlation Between Phio Pharmaceuticals and Editas Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Editas Medicine, you can compare the effects of market volatilities on Phio Pharmaceuticals and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Editas Medicine.

Diversification Opportunities for Phio Pharmaceuticals and Editas Medicine

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Phio and Editas is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Editas Medicine go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and Editas Medicine

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 1.52 times more return on investment than Editas Medicine. However, Phio Pharmaceuticals is 1.52 times more volatile than Editas Medicine. It trades about -0.08 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.33 per unit of risk. If you would invest  293.00  in Phio Pharmaceuticals Corp on August 24, 2024 and sell it today you would lose (40.00) from holding Phio Pharmaceuticals Corp or give up 13.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  Editas Medicine

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Editas Medicine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Editas Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Phio Pharmaceuticals and Editas Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and Editas Medicine

The main advantage of trading using opposite Phio Pharmaceuticals and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.
The idea behind Phio Pharmaceuticals Corp and Editas Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum